Gynecological medicine products represent a major, dynamic, and rapidly growing market in the U.S. Factors driving this market include the aging of the female population, accompanied by advances in medical treatments for conditions that affect adult women of all ages. This has resulted in greatly increased demand for healthcare products for the management of benign uterine conditions, contraception, incontinence, infertility, and osteoporosis.

New pharmaceutical compounds are expected to enjoy the greatest gains in the osteoporosis, incontinence, and reproductive medicine market segments, as they have application to broad population groups. Devices markets such as stress incontinence surgery products, periurethral bulking agents, nerve stimulators, urethral prostheses and inserts, outpatient endometrial ablation systems, and hysteroscopic fluid management systems are also forecast to see significant increases in compound annual growth rates during the forecast period covered by this report.

Major topics addressed in this report from Medtech Insight include: analysis of technologies, product markets, competitors, and trends as well as 34 company profiles. Products and technologies include: afferent nerve stimulators; artificial urinary sphincters; bone densitometers; contraceptive devices; cystoscopes; drug options for incontinence, menorrhagia, infertility, and osteoporosis; extracorporeal magnetic innervation systems; fluid management systems; hysteroscopes; infertility catheters; minimally invasive treatments; office-based diagnostic ultrasound systems; operative hysteroscopy disposables; osteoporosis biochemical markers; outpatient/office endometrial ablation systems; pelvic exercisers; periurethral bulking agents; stress incontinence surgery products; urethral prostheses and inserts; urodynamic studies systems; and uterine manipulators.

TABLE OF CONTENTS

EXECUTIVE SUMMARY

     i. Benign Uterine Conditions

     ii. Reproduction

     iii. Incontinence

     iv. Osteoporosis

     v. Suppliers

1. MANAGEMENT OF BENIGN UTERINE CONDITIONS

     1.1 Types

          1.1.1 Fibroids

          1.1.2 Endometriosis

          1.1.3 Menorrhagia

     1.2 Treatment Options

          1.2.1 Drug Therapy

          1.2.2 Interventions for Menorrhagia

                  1.2.2.1 Dilation and Curettage  

                  1.2.2.2 Hysterectomy

                  1.2.2.3 Surgical Endometrial Ablation        

                             1.2.2.3.1 Hysteroscopy

                             1.2.2.3.2 Complications and Intravasation of
                                          Distending Media

                             1.2.2.3.3 Ablation Techniques

                             1.2.2.3.4 Physicians and Hysteroscopy

                             1.2.2.3.5 Costs

                             1.2.2.3.6 Procedures

                  1.2.2.4 Global Endometrial Ablation

                             1.2.2.4.1 Technique

                             1.2.2.4.2 Ablation Approaches

                             1.2.2.4.3 Costs

                             1.2.2.4.4 Procedure Volumes

          1.2.3 Fibroid Removal

                  1.2.3.1 Myomectomy

                             1.2.3.1.1 Myomectomy via Laparotomy

                             1.2.3.1.2 Laparoscopic Myomectomy

                             1.2.3.1.3 Hysteroscopic Resection

                             1.2.3.1.4 Laparoscopically Assisted Myomectomy

                  1.2.3.2 Myolysis and Cryomyolysis

                  1.2.3.3 Transcatheter Uterine Artery Embolization

                  1.2.3.4 High-Intensity Focused Ultrasound

          1.2.4 Resection of Endometriosis

                  1.2.4.1 Current Surgical Options

                  1.2.4.2 Photodynamic Therapy

     1.3 Products

          1.3.1 Uterine Manipulators

          1.3.2 Hysteroscopes and Related Products

                  1.3.2.1 Hysteroscopes and Systems

                             1.3.2.1.1 BEI Medical Systems

                             1.3.2.1.2 Circon

                             1.3.2.1.3 CooperSurgical

                             1.3.2.1.4 Gynecare

                             1.3.2.1.5 Leisegang Medical

                             1.3.2.1.6 Olympus America

                             1.3.2.1.7 Karl Storz Endoscopy-America

                             1.3.2.1.8 Richard Wolf Medical Instruments

                 1.3.2.2 Fluid Management Systems

                             1.3.2.2.1 Circon

                             1.3.2.2.2 Davol

                             1.3.2.2.3 Gynecare

                             1.3.2.2.4 Olympus America

                             1.3.2.2.5 Karl Storz Endoscopy-America

                             1.3.2.2.6 Richard Wolf Medical Instruments

          1.3.3 Global Endometrial Ablation Systems

                  1.3.3.1 BEI Medical Systems

                  1.3.3.2 Gynecare

                  1.3.3.3 InnerDyne

                  1.3.3.4 Wallsten Medical

                  1.3.3.5 Novacept

                  1.3.3.6 Atos Medical

                  1.3.3.7 Valleylab

                  1.3.3.8 Microsulis

                  1.3.3.9 CryoGen

     1.4 Product Markets

          1.4.1 Hysteroscopy Systems and Accessories

                  1.4.1.1 Hysteroscopes

                  1.4.1.2 Electrode Accessories

          1.4.2 Fluid Management Products

          1.4.3 Disposable Uterine Manipulators

          1.4.4 Global Endometrial Ablation Systems

2. REPRODUCTION MANAGEMENT

     2.1 Overview of Female Reproduction

     2.2 Contraception

          2.2.1 Methods

                  2.2.1.1 Oral Contraceptives

                             2.2.1.1.1 Composition

                             2.2.1.1.2 Mechanism of Action

                             2.2.1.1.3 Formulations

                             2.2.1.1.4 Adverse Effects

                             2.2.1.1.5 Product Trends

                  2.2.1.2 Contraceptive Implants

                  2.2.1.3 Progestin Injections

                  2.2.1.4 Intrauterine Devices

                  2.2.1.5 Diaphragms and Cervical Caps

                  2.2.1.6 Female Condoms

                  2.2.1.7 Vaginal Sponge

                  2.2.1.8 Emergency Contraception

                  2.2.1.9 Sterilization

                  2.2.1.10 Vaginal Rings

          2.2.2 Developments in Contraception

                  2.2.2.1 Mifepristone

                  2.2.2.2 Contraceptive Patch

                  2.2.2.3 Male Contraceptive Pill

                  2.2.2.4 Contraceptive Vaccine

                  2.2.2.5 Menses Induction

                  2.2.2.6 An Infertility-Linked Gene

                  2.2.2.7 Fertility Calculator

                  2.2.2.8 Advances in Spermicides

          2.2.3 Contraceptive Products Market Analyses

                  2.2.3.1 Contraceptive Drugs

                  2.2.3.2 Contraceptive Devices

     2.3 Developments in Infertility Management

          2.3.1 Prevalence

          2.3.2 Causes

                  2.3.2.1 Tubal Infertility

                  2.3.2.2 Endometriosis

                  2.3.2.3 Hormonal Factors

          2.3.3 Diagnostic Procedures

                  2.3.3.1 Blood Tests

                  2.3.3.2 Tissue Examination

                  2.3.3.3 Endoscopic Examination of Fallopian Tubes
                             and Uterus

                             2.3.3.3.1 Hysterosalpingography/
                                          Hysterosonography

                             2.3.3.3.2 Chromopertubation

                             2.3.3.3.3 Falloposcopy

          2.3.4 Fertility Treatments

                  2.3.4.1 Drug Therapy

                             2.3.4.1.1 Types and Products

                             2.3.4.1.2 Suppliers

                  2.3.4.2 Surgery

                  2.3.4.3 Intrauterine Insemination

                  2.3.4.4 Assisted Reproductive Technologies

                  2.3.4.5 Specialty Infertility Products

                             2.3.4.5.1 Embryo Transfer Catheters

                             2.3.4.5.2 Intrauterine Insemination Catheters

                             2.3.4.5.3 Hysterosalpingography and
                                          Hysterosonography Catheters

                  2.3.4.6 Developments in Infertility Management

                             2.3.4.6.1 Blastocyte Embryo Transfer

                             2.3.4.6.2 Trans-Uterine Fallopian Transfer/
                                          Hysteroscopic Uterine Transfer

                             2.3.4.6.3 Antagon

                             2.3.4.6.4 Egg Banks

                  2.3.4.7 Infertility Products Market Analyses

                             2.3.4.7.1 Pharmaceuticals

                             2.3.4.7.2 Specialty Catheters

3. URINARY INCONTINENCE

     3.1 Types and Causes

          3.1.1 Stress Urinary Incontinence

          3.1.2 Urge Incontinence

          3.1.3 Mixed Incontinence

          3.1.4 Overflow Incontinence

          3.1.5 Other Types of Incontinence

     3.2 Providers and Treatment Sites

     3.3 Patient Forecasts

     3.4 Diagnostic Protocols and Products

          3.4.1 Basic Evaluation

                  3.4.1.1 Patient History

                  3.4.1.2 Physical Examination

                  3.4.1.3 Post-Void Residual Volume

                  3.4.1.4 Urinalysis

                  3.4.1.5 Other Tests

                  3.4.1.6 Treatment Route

          3.4.2 Specialized Tests

                  3.4.2.1 Urodynamic Studies

                             3.4.2.1.1 Equipment and Suppliers

                             3.4.2.1.2 Installations and Specialists
                                          Performing Procedures

                             3.4.2.1.3 Procedures

                  3.4.2.2 Cystoscopy/Cystourethroscopy

                             3.4.2.2.1 Equipment

                             3.4.2.2.2 Procedures

                  3.4.2.3 Imaging

                             3.4.2.3.1 Technique

                             3.4.2.3.2 Equipment and Suppliers

                             3.4.2.3.3 Installations and Procedures

     3.5 Current and Emerging Treatment Options

          3.5.1 Behavioral Therapies

                  3.5.1.1 Toileting Assistance

                  3.5.1.2 Bladder Training

                  3.5.1.3 Pelvic Muscle Rehabilitation

                             3.5.1.3.1 Pelvic Muscle Exercises

                             3.5.1.3.2 Biofeedback Therapy

                             3.5.1.3.3 Vaginal Weight Training

                             3.5.1.3.4 Pelvic Floor Stimulation

          3.5.2 Incontinence Management Systems

          3.5.3 Drug Therapy

                  3.5.3.1 Drug Options for Urge Incontinence

                             3.5.3.1.1 Anticholinergic Agents

                             3.5.3.1.2 Detrol

                             3.5.3.1.3 Ditropan XL

                             3.5.3.1.4 Other Anticholinergics

                             3.5.3.1.5 Tricyclic Agents

                             3.5.3.1.6 Calcium Channel Blockers

                  3.5.3.2 Drug Options for Stress Urinary Incontinence

                             3.5.3.2.1 Alpha-Adrenergic Agonists

                             3.5.3.2.2 Estrogen

                  3.5.3.3 Drug Options for Overflow Incontinence

                  3.5.3.4 Product Developments

                             3.5.3.4.1 S-Oxybutynin

                             3.5.3.4.2 NS-49

                             3.5.3.4.3 Darifenacin

                             3.5.3.4.4 Lu 25-109

                             3.5.3.4.5 Duloxetine

                             3.5.3.4.6 Resiniferatoxin

                             3.5.3.4.7 Capsaicin

                             3.5.3.4.8 Other Approaches

          3.5.4 Surgical Therapy

                  3.5.4.1 Treatments to Correct Bladder Neck Hypermobility

                             3.5.4.1.1 Retropubic Urethropexy

                             3.5.4.1.2 Transvaginal Needle Bladder
                                          Neck Suspension

                             3.5.4.1.3 Anterior Vaginal and Abdominal
                                          Paravaginal Repairs

                  3.5.4.2 Treatments to Correct Intrinsic
                             Sphincter Deficiency

                             3.5.4.2.1 Sling Procedures

                             3.5.4.2.2 Tension-Free Vaginal Tape Procedure

                             3.5.4.2.3 Artificial Urinary Sphincters

                  3.5.4.3 Surgical Options for Detrusor Instability

                             3.5.4.3.1 Augmentation Intestinocystoplasty

                             3.5.4.3.2 Urinary Diversion

                  3.5.4.4 Treatments to Remove Outlet Obstruction

                  3.5.4.5 Surgery Enhancement Products

                             3.5.4.5.1 Bone Anchor Systems

                             3.5.4.5.2 Sling Materials and Products

          3.5.5 Periurethral Bulking Treatments

                  3.5.5.1 Inamed/C.R. Bard

                  3.5.5.2 Advanced UroScience

                  3.5.5.3 American Medical Systems

                  3.5.5.4 Biomatrix

                  3.5.5.5 Collagenesis

                  3.5.5.6 Genyx Medical

                  3.5.5.7 LifeCell Corporation

                  3.5.5.8 Mentor

                  3.5.5.9 Organogenesis

                  3.5.5.10 Protein Polymer Technologies

                  3.5.5.11 Q-Med

                  3.5.5.12 Reprogenesis

                  3.5.5.13 Uroplasty

          3.5.6 Urethral Prostheses and Inserts

                  3.5.6.1 ContiMed

                  3.5.6.2 HK Medical Technologies

                  3.5.6.3 Influence

                  3.5.6.4 Rochester Medical

                  3.5.6.5 TAMA Medical

                  3.5.6.6 UroMed

                  3.5.6.7 UroQuest Medical

          3.5.7 Nerve Stimulators

                  3.5.7.1 Medtronic

                  3.5.7.2 UroSurge

                  3.5.7.3 NEOTONUS

     3.6 Market Forecasts

          3.6.1 Urodynamic Studies Products

          3.6.2 Office-Based Ultrasound Systems

          3.6.3 Incontinence Drugs

          3.6.4 Incontinence Therapy Devices

                  3.6.4.1 Stress Incontinence Surgery Products

                             3.6.4.1.1 Sling Products and Bone
                                          Anchor Systems

                             3.6.4.1.2 Tension-Free Vaginal Tape Products

                  3.6.4.2 Artificial Urinary Sphincters

                  3.6.4.3 Urethral Prostheses and Inserts

                  3.6.4.4 Bulking Agents

                  3.6.4.5 Pelvic Exercisers and Other Behavioral
                            Therapy Products

                  3.6.4.6 Nerve Stimulation Products

                             3.6.4.6.1 Sacral Nerve Stimulators

                             3.6.4.6.2 Pelvic Muscle Nerve Stimulators

4. OSTEOPOROSIS

     4.1 Overview of Osteoporosis

          4.1.1 Incidence, Prevalence, and Cost

          4.1.2 Types

          4.1.3 Risk Factors

     4.2 Diagnosis

          4.2.1 Bone Densitometry

                  4.2.1.1 Indications

                  4.2.1.2 Products by Application

                             4.2.1.2.1 Hospital-Based Densitometry Systems

                             4.2.1.2.2 Office-Based Densitometry Systems

                             4.2.1.2.3 Software-Based Systems

                  4.2.1.3 Products and Suppliers

                  4.2.1.4 Market Analyses

          4.2.2 Biochemical Markers

                  4.2.2.1 Types

                  4.2.2.2 Applications

                  4.2.2.3 Products and Suppliers

                             4.2.2.3.1 Ostex International

                             4.2.2.3.2 Metra Biosystems

                             4.2.2.3.3 Osteometer Biotech

                             4.2.2.3.4 Orion Diagnostica

                             4.2.2.3.5 Other Companies

                  4.2.2.4 Market Analyses

     4.3 Treatment

          4.3.1 Anti-Resorptive Drugs

                  4.3.1.1 Estrogen

                  4.3.1.2 Selective Estrogen Receptor Modulators

                  4.3.1.3 Calcitonins

                  4.3.1.4 Bisphosphonates

          4.3.2 Bone Forming Drugs

                  4.3.2.1 Sodium Fluoride

                  4.3.2.2 Parathyroid Hormone

          4.3.3 Other Treatments

                  4.3.3.1 Isoflavones

                  4.3.3.2 Osteoprotegerin

                  4.3.3.3 Gene Therapy

                  4.3.3.4 Statin Drugs

                  4.3.3.5 Activators of Non-Genomic Estrogen-Like Signaling

          4.3.4 Market Analyses

                  4.3.4.1 Hormone Replacement Therapy Drugs

                  4.3.4.2 Osteoporosis Drugs

                  4.3.4.3 Share by Supplier

5. COMPANY PROFILES

     5.1   Advanced UroScience, Inc.

     5.2   ALZA Corporation

     5.3   American Medical Systems

     5.4   Ares-Serono Group SA

     5.5   BEI Medical Systems Company, Inc.

     5.6   Circon Corporation/Maxxim Medical, Inc.

     5.7   CooperSurgical, Inc./The Cooper Companies, Inc.

     5.8   CryoGen, Inc.

     5.9   Davol, Inc./C.R. Bard, Inc.

     5.10 Empi, Inc.

     5.11 Hologic, Inc.

     5.12 Hybritech, Inc./Beckman Coulter, Inc.

     5.13 Influence, Inc.

     5.14 Johnson & Johnson

            5.14.1 Gynecare, Inc./Johnson & Johnson

            5.14.2 Ortho-McNeil Pharmaceutical/Johnson & Johnson

     5.15 Laborie Medical Technologies Corporation

     5.16 Life-Tech, Inc.

     5.17 Eli Lilly and Company

     5.18 Lunar Corporation

     5.19 Mentor Corporation

     5.20 Merck & Company, Inc.

     5.21 Metra Biosystems, Inc./Quidel Corporation

     5.22 Microsulis Corporation/AccuMed International, Inc.

     5.23 Microvasive/Boston Scientific Corporation

     5.24 NEOTONUS, Inc.

     5.25 Norland Medical Systems, Inc.

     5.26 Olympus America, Inc.

     5.27 Ostex International, Inc.

     5.28 Pharmacia & Upjohn, Inc.

     5.29 Rochester Medical Corporation

     5.30 Karl Storz Endoscopy-America, Inc./Karl Storz GmbH

     5.31 UroSurge, Inc.

     5.32 Utah Medical Products, Inc.

     5.33 Richard Wolf Medical Instruments Corporation/
            Richard Wolf GmbH

     5.34 Wyeth-Ayerst Laboratories, Inc./
            American Home Products Corporation

COMPANY LISTING

LIST OF EXHIBITS

Exhibit ES-1:  Gynecologic Drugs and Devices, Market Forecast, 1998-2004 

Exhibit ES-2:  Products Used to Manage Benign Uterine Conditions, Market Forecast, 1998-2004 

Exhibit ES-3:  Reproduction Drugs and Devices, Market Forecast, 1998-2004 

Exhibit ES-4:  1999, Emerging Treatment Options for Urinary Incontinence, Selected Manufacturers 

Exhibit ES-5:  Incontinence Drugs and Devices, Market Forecast, 1998-2004 

Exhibit ES-6:  Osteoporosis Drugs and Devices, Market Forecast, 1998-2004 

Exhibit ES-7:  1999, Leading Suppliers of Gynecologic Drugs 

Exhibit ES-8:  1999, Leading Suppliers of Gynecologic Devices 

Exhibit 1-1:    Types and Locations of Uterine Fibroids 

Exhibit 1-2:    Principal Locations of Endometrial Implants 

Exhibit 1-3:    Endometriosis Staging 

Exhibit 1-4:    Dilation and Curettage, Procedure Volumes Forecast, 1998-2004 

Exhibit 1-5:    1999, Current and Emerging Procedures Alternative to Hysterectomy for the Treatment of Uterine Fibroids and Menorrhagia 

Exhibit 1-6:    Hysterectomy, Procedure Volumes Forecast, 1998-2004 

Exhibit 1-7:    Techniques Used for Surgical Endometrial Ablation 

Exhibit 1-8:    Cost Comparison of Surgical Endometrial Ablation versus Hysterectomy for the Treatment of Menorrhagia 

Exhibit 1-9:    Operative Hysteroscopy, Procedure Volumes Forecast, 1998-2004 

Exhibit 1-10:  Global Endometrial Ablation, Procedure Volumes Forecast, 1998-2004 

Exhibit 1-11:  1999, Current and Emerging Approaches to Fibroid Removal 

Exhibit 1-12:  Comparison of Laparoscopic and Open Myomectomy Procedures 

Exhibit 1-13:  Advantages and Disadvantages of Photodynamic Therapy for the Treatment of Endometriosis 

Exhibit 1-14:  Reusable, Disposable, and Hybrid Uterine Manipulators 

Exhibit 1-15:  1999, Selected Hysteroscopes and Systems 

Exhibit 1-16:  1999, Selected Fluid Management Systems 

Exhibit 1-17:  1999, Current and Emerging Global Endometrial Ablation Systems 

Exhibit 1-18:  Comparison of ThermaChoice Uterine Balloon Therapy System and Rollerball Ablation 

Exhibit 1-19:  Results of Extirpated Uterus and Pre-Hysterectomy Studies Using Novacept’s NovaSure Endometrial Ablation System

Exhibit 1-20:  Characteristics of the Microwave Endometrial Ablation System 

Exhibit 1-21:  Benign Uterine Condition Management Products, Market Forecast, 1998-2004 

Exhibit 1-22:  Hysteroscopy Systems and Accessories, Market Forecast, 1998-2004 

Exhibit 1-23:  Hysteroscopes, Market Forecast, 1998-2004 

Exhibit 1-24:  1999, Hysteroscopes Market, Share by Supplier 

Exhibit 1-25:  Electrode Accessories, Market Forecast, 1998-2004 

Exhibit 1-26:  1999, Hysteroscopy Electrode Accessories Market, Share by Supplier 

Exhibit 1-27:  Fluid Management Products, Market Forecast, 1998-2004

Exhibit 1-28:  Fluid Management Systems and Tubing Sets, Market Forecast, 1998-2004 

Exhibit 1-29:  1999, Fluid Management Products Market, Share by Supplier 

Exhibit 1-30:  Disposable Uterine Manipulators, Market Forecast, 1998-2004 

Exhibit 1-31:  1999, Disposable Uterine Manipulators Market, Share by Supplier 

Exhibit 1-32:  Global Endometrial Ablation Systems, by Modality Type, Market Forecast, 1998-2004 

Exhibit 1-33:  Hydrothermal Endometrial Ablation Systems, Market Forecast, 1998-2004 

Exhibit 1-34:  Radiofrequency Endometrial Ablation Systems, Market Forecast, 1998-2004 

Exhibit 1-35:  Endometrial Cryoablation Systems, Market Forecast, 1998-2004 

Exhibit 1-36:  Microwave Endometrial Ablation Systems, Market Forecast, 1998-2004 

Exhibit 2-1:    Mechanisms of Natural Female Fertility 

Exhibit 2-2:    1999, Current and Emerging Methods of Female Contraception 

Exhibit 2-3:    Selected Oral Contraceptives 

Exhibit 2-4:    1999, Selected Current and Emerging Contraceptive Implants 

Exhibit 2-5:    Intrauterine Device Indications and Contraindications 

Exhibit 2-6:    Tubal Ligations, Procedure Volumes Forecast, 1998-2004

Exhibit 2-7:    Female Contraceptive Products, Market Forecast, 1998-2004 

Exhibit 2-8:    Contraceptive Drugs, Market Forecast, 1998-2004 

Exhibit 2-9:    Contraceptive Drugs, By Type, Market Forecast, 1998-2004 

Exhibit 2-10:  1999, Contraceptive Drugs, Share by Supplier 

Exhibit 2-11:  Contraceptive Devices, Market Forecast, 1998-2004 

Exhibit 2-12:  Procedures Used to Diagnose Infertility 

Exhibit 2-13:  Hysterosalpingography and Hysterosonography, Procedure Volumes Forecasts, 1998-2004 

Exhibit 2-14:  Approaches Used in Infertility Management 

Exhibit 2-15:  Overview of Pharmacological Approaches to Infertility Management 

Exhibit 2-16:  Overview of Surgical Approaches to Infertility Management

Exhibit 2-17:  Assisted Reproductive Technologies 

Exhibit 2-18:  Distribution of Assisted Reproductive Technology Procedures and Diagnoses, 1994-1996 

Exhibit 2-19:  Infertility Products, Market Forecast, 1998-2004 

Exhibit 2-20:  Infertility Drugs, Market Forecast, 1998-2004 

Exhibit 2-21:  Infertility Drugs, by Type, Market Forecast, 1998-2004 

Exhibit 2-22:  1999, Infertility Drugs Market, Share by Supplier 

Exhibit 2-23:  Specialty Infertility Catheters, Market Forecast, 1998-2004 

Exhibit 2-24:  Specialty Infertility Catheters, by Type, Market Forecast, 1998-2004 

Exhibit 2-25:  1999, Infertility Drugs Market, Share by Supplier 

Exhibit 3-1:    Features and Types of Urinary Incontinence 

Exhibit 3-2:    Stress Urinary Incontinence Classifications 

Exhibit 3-3:    Female Incontinence, Cases Forecast by Type, 1998-2004

Exhibit 3-4:    Agency for Health Care Policy and Research Guidelines for Incontinence—Criteria for Further Evaluation of Incontinence Patients 

Exhibit 3-5:    Urodynamic Testing and Applications 

Exhibit 3-6:    1999, Selected Office-Based Urodynamics Systems 

Exhibit 3-7:    1999, Major Urodynamic Studies Performed, by Type and Site 

Exhibit 3-8:    Urodynamics Studies, Procedure Volumes Forecasts by Type, 1998-2004 

Exhibit 3-9:    1999, Selected Office-Based Diagnostic Ultrasound Scanners 

Exhibit 3-10:  Office-Based Ultrasound for Urologic Evaluation, Procedure Volumes Forecast, 1998-2004 

Exhibit 3-11:  Treatment Options for Urinary Incontinence 

Exhibit 3-12:  Stress Urinary Incontinence Treatments, Procedure Volumes Forecast, 1998-2004 

Exhibit 3-13:  Urge Incontinence Treatments, Procedure Volumes Forecast, 1998-2004 

Exhibit 3-14:  1999, Selected Incontinence Behavioral Therapy Products

Exhibit 3-15:  Selected Developments in Drug Therapy for Incontinence

Exhibit 3-16:  Available Surgical Treatment Options for the Correction of Bladder Neck Hypermobility and Intrinsic Sphincter Deficiency 

Exhibit 3-17:  Major Transvaginal Needle Suspension Procedures 

Exhibit 3-18:  Comparative Outcomes for Stress Urinary Incontinence Surgical Procedures 

Exhibit 3-19:  The Surgically Implanted Artificial Urinary Sphincter in the Female Patient 

Exhibit 3-20:  1999, Selected Bone Anchor Systems 

Exhibit 3-21:  1999, Selected Sling Procedure Products 

Exhibit 3-22:  1999, Selected Bulking Agents 

Exhibit 3-23:  1999, Selected Urethral Prostheses and Inserts 

Exhibit 3-24:  1999, Selected Nerve Stimulation Devices for the Treatment of Urge Incontinence 

Exhibit 3-25:  Incontinence Products, Market Forecast, 1998-2004 

Exhibit 3-26:  Urodynamic Studies Products, Market Forecast, 1998-2004 

Exhibit 3-27:  Urodynamic Studies Systems, Market Forecast, 1998-2004

Exhibit 3-28:  Urodynamic Studies Consumables, Market Forecast, 1999-2004 

Exhibit 3-29:  1999, Urodynamic Studies Products Market, Share by Supplier 

Exhibit 3-30:  Office-Based Ultrasound Systems, Market Forecast, 1998-2004 

Exhibit 3-31:  Office-Based Obstetric/Gynecologic Ultrasound Systems, Market Forecast, 1998-2004 

Exhibit 3-32:  Transrectal Ultrasound Systems, Market Forecast, 1998-2004 

Exhibit 3-33:  1999, Office-Based Obstetric/Gynecologic Ultrasound Systems Market, Share by Supplier 

Exhibit 3-34:  1999, Office-Based Transrectal Ultrasound Systems Market, Share by Supplier 

Exhibit 3-35:  Incontinence Pharmaceuticals, Market Forecast, 1998-2004 

Exhibit 3-36:  Standard Incontinence Drugs, Market Forecast, 1998-2004 

Exhibit 3-37:  Detrol, Market Forecast, 1998-2004 

Exhibit 3-38:  Ditropan XL, Market Forecast, 1998-2004 

Exhibit 3-39:  New Incontinence Drugs, Market Forecast, 1998-2004 

Exhibit 3-40:  1999, Incontinence Drugs Market, Share by Supplier 

Exhibit 3-41:  Incontinence Therapy Devices, Market Forecast, 1998-2004 

Exhibit 3-42:  Major Types of Stress Urinary Incontinence Surgery, Procedure Volumes Forecast, 1998-2004 

Exhibit 3-43:  Stress Incontinence Surgery Products, Market Forecast, 1998-2004 

Exhibit 3-44:  Sling Products, Market Forecast, 1998-2004 

Exhibit 3-45:  Bone Anchor Products, Market Forecast, 1998-2004 

Exhibit 3-46:  1999, Sling and Bone Anchor Products Market, Share by Supplier 

Exhibit 3-47:  Tension-Free Vaginal Tape Products, Market Forecast, 1998-2004 

Exhibit 3-48:  Artificial Urinary Sphincters, Market Forecast, 1998-2004

Exhibit 3-49:  Urethral Prostheses and Inserts, Market Forecast, 1998-2004 

Exhibit 3-50:  1999, Urethral Prostheses and Inserts Market, Share by Supplier 

Exhibit 3-51:  Bulking Agents, Market Forecast, 1998-2004 

Exhibit 3-52:  Pelvic Exercisers and Other Behavioral Therapy Products, Market Forecast, 1998-2004 

Exhibit 3-53:  1999, Pelvic Exercisers and Other Behavioral Therapy Products Market, Share by Supplier 

Exhibit 3-54:  Nerve Stimulation Products, Market Forecast, 1998-2004

Exhibit 3-55:  Sacral Nerve Stimulation Products, Market Forecast, 1998-2004 

Exhibit 3-56:  Extracorporeal Magnetic Innervation Devices, Market Forecast, 1998-2004 

Exhibit 4-1:    Types of Osteoporosis 

Exhibit 4-2:    Risk Factors for Primary Osteoporosis 

Exhibit 4-3:    Comparison of Bone Densitometry and Osteoporosis Biochemical Markers 

Exhibit 4-4:    Imaging Technologies Used to Diagnose Osteoporosis 

Exhibit 4-5:    1996, Clinical Comparison of Bone Measurement Techniques 

Exhibit 4-6:    1999, Selected Bone Densitometry Systems 

Exhibit 4-7:    Bone Densitometry Systems, Market Forecast, 1998-2004

Exhibit 4-8:    1998 and 1998, Bone Densitometry Systems Market, Share by Supplier 

Exhibit 4-9:    Selected Bone Remodeling Biochemical Markers 

Exhibit 4-10:  1999, Selected Current and Emerging Bone Remodeling Biochemical Marker Tests 

Exhibit 4-11:  Bone Remodeling Biochemical Markers, Market Forecast, 1998-2004 

Exhibit 4-12:  1999, Bone Remodeling Biochemical Markers Market, Share by Supplier 

Exhibit 4-13:  1999, Selected Current and Emerging Pharmaceutical Treatments for Osteoporosis 

Exhibit 4-14:  Osteoporosis Therapy and Hormone Replacement Therapy Drugs, Market Forecast, 1998-2004 

Exhibit 4-15:  Hormone Replacement Therapy Drugs, Market Forecast, 1998-2004 

Exhibit 4-16:  Osteoporosis Therapy Drugs, Market Forecast, 1998-2004

Exhibit 4-17:  1999, Osteoporosis Therapy and Hormone Replacement Therapy Drugs Market, Share by Supplier 

Copyright 2000, Medtech Insight, LLC